XETR
MAK
Market cap20mUSD
Oct 07, Last price
0.89EUR
1D
-0.56%
1Q
-7.29%
Jan 2017
-29.37%
Name
MATERNUS-Kliniken AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Maternus-Kliniken AG oversees a network of facilities that includes retirement and nursing residences, rehabilitation centers, and a variety of specialized service companies. This enterprise primarily focuses on delivering geriatric care and medical rehabilitation services. Furthermore, it offers an extensive range of support options, such as emergency response systems, assisted living arrangements, and various care modalities including home care, residential care, temporary stays, and care for individuals with disabilities. Its services also encompass comprehensive rehabilitation and post-treatment programs. The company maintains roughly 23 establishments throughout Germany. Founded in 1877, Maternus-Kliniken AG's corporate headquarters are situated in Berlin, Germany.
Key people
Chairman of the Supervisory Board
Michael Thanheiser
Member of the Management Board · since 2017
Sven Olschar
Deputy Chairman of the Supervisory Board, Employee Representative
Joerg Arnold
Member of the Supervisory Board, Employee Representative
Christel Birkenkamp
Member of the Supervisory Board, Employee Representative
Dietmar Erdmeier
Member of the Supervisory Board, Employee Representative
Chris Recke
Member of the Supervisory Board, Employee Representative
Daniela Rossa-Heise
Member of the Supervisory Board
Helmuth Spincke
Member of the Supervisory Board
Agnes Westerheide
Member of the Supervisory Board, Employee Representative
Member of the Supervisory Board · since 2018
Headquarters & legal address
Französische Strasse 53-55
Berlin, BE 10117
DE
Berlin, BE 10117
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||